Stock Analysis on Net
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Total Asset Turnover
since 2005

Microsoft Excel

Calculation

Biogen Inc., total asset turnover, long-term trends, calculation

Microsoft Excel
Total asset turnover = Revenues1 ÷ Total assets1
Dec 31, 2021 0.46 = 10,981,700 ÷ 23,877,300
Dec 31, 2020 0.55 = 13,444,600 ÷ 24,618,900
Dec 31, 2019 0.53 = 14,377,900 ÷ 27,234,300
Dec 31, 2018 0.53 = 13,452,900 ÷ 25,288,900
Dec 31, 2017 0.52 = 12,273,900 ÷ 23,652,600
Dec 31, 2016 0.50 = 11,448,800 ÷ 22,876,800
Dec 31, 2015 0.55 = 10,763,800 ÷ 19,504,800
Dec 31, 2014 0.68 = 9,703,324 ÷ 14,316,559
Dec 31, 2013 0.58 = 6,932,199 ÷ 11,863,335
Dec 31, 2012 0.54 = 5,516,461 ÷ 10,130,118
Dec 31, 2011 0.56 = 5,048,634 ÷ 9,049,604
Dec 31, 2010 0.58 = 4,716,423 ÷ 8,092,493
Dec 31, 2009 0.51 = 4,377,348 ÷ 8,551,854
Dec 31, 2008 0.48 = 4,097,507 ÷ 8,478,991
Dec 31, 2007 0.37 = 3,171,617 ÷ 8,628,815
Dec 31, 2006 0.31 = 2,683,049 ÷ 8,552,808
Dec 31, 2005 0.29 = 2,422,500 ÷ 8,366,947

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands

Comparison to Competitors

Biogen Inc., total asset turnover, long-term trends, comparison to competitors

Microsoft Excel
Biogen Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc. Zoetis Inc.
Dec 31, 2021 0.46 0.38 0.40 0.42 0.35 0.58 0.40 0.52 0.46 0.45 0.63 0.41 0.56
Dec 31, 2020 0.55 0.30 0.39 0.36 0.29 0.53 0.36 0.47 0.52 0.27 0.50 0.47 0.49
Dec 31, 2019 0.53 0.37 0.37 0.20 0.29 0.57 0.36 0.52 0.55 0.31 0.53 0.44 0.54
Dec 31, 2018 0.53 0.55 0.34 0.64 0.42 0.56 0.34 0.53 0.51 0.34 0.57 0.43 0.54
Dec 31, 2017 0.52 0.40 0.27 0.62 0.39 0.51 0.37 0.49 0.46 0.31 0.67 0.37 0.62
Dec 31, 2016 0.50 0.39 0.28 0.58 0.37 0.55 0.53 0.51 0.42 0.31 0.70 0.40 0.64
Dec 31, 2015 0.55 0.43 0.29 0.52 0.43 0.56 0.62 0.53 0.39 0.29 0.73 0.41 0.60
Dec 31, 2014 0.68 0.72 0.28 0.47 0.54 0.53 0.71 0.57 0.43 0.29 0.73 0.39 0.72
Dec 31, 2013 0.58 0.64 0.28 0.42 0.55 0.66 0.48 0.54 0.42 0.30 0.71 0.41 0.70
Dec 31, 2012 0.54 0.68 0.31 0.49 0.55 0.66 0.44 0.55 0.45 0.32 0.66 0.46 0.69
Dec 31, 2011 0.56 — 0.31 0.64 0.54 0.72 0.47 0.57 0.46 0.36 0.34 0.44 —
Dec 31, 2010 0.58 — 0.34 0.63 0.59 0.74 0.64 0.60 0.43 0.35 0.42 0.51 —
Dec 31, 2009 0.51 — 0.36 0.61 0.57 0.80 0.67 0.65 0.24 0.23 0.51 0.47 —
Dec 31, 2008 0.48 — 0.40 0.70 0.73 0.70 0.72 0.75 0.51 0.43 0.36 0.50 —
Dec 31, 2007 0.37 — 0.41 0.74 0.63 0.70 0.64 0.75 0.50 0.42 0.13 0.46 —
Dec 31, 2006 0.31 — 0.41 0.70 0.75 0.71 0.63 0.76 0.51 0.42 0.11 0.18 —
Dec 31, 2005 0.29 — 0.41 0.68 0.87 0.60 0.48 0.87 0.49 0.44 0.16 0.62 —

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Biogen Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Biogen Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2021 0.46 0.44
Dec 31, 2020 0.55 0.39
Dec 31, 2019 0.53 0.39
Dec 31, 2018 0.53 0.45
Dec 31, 2017 0.52 0.40
Dec 31, 2016 0.50 0.42
Dec 31, 2015 0.55 0.42
Dec 31, 2014 0.68 0.45
Dec 31, 2013 0.58 0.43
Dec 31, 2012 0.54 0.45
Dec 31, 2011 0.56 0.46
Dec 31, 2010 0.58 0.47
Dec 31, 2009 0.51 0.39
Dec 31, 2008 0.48 0.57
Dec 31, 2007 0.37 0.56
Dec 31, 2006 0.31 0.54
Dec 31, 2005 0.29 0.57

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Biogen Inc., total asset turnover, long-term trends, comparison to industry (health care)

Microsoft Excel
Biogen Inc. Health Care
Dec 31, 2021 0.46 0.76
Dec 31, 2020 0.55 0.70
Dec 31, 2019 0.53 0.71
Dec 31, 2018 0.53 0.67
Dec 31, 2017 0.52 0.68
Dec 31, 2016 0.50 0.70
Dec 31, 2015 0.55 0.67
Dec 31, 2014 0.68 0.72
Dec 31, 2013 0.58 0.69
Dec 31, 2012 0.54 0.69
Dec 31, 2011 0.56 0.70
Dec 31, 2010 0.58 0.69
Dec 31, 2009 0.51 0.64
Dec 31, 2008 0.48 0.81
Dec 31, 2007 0.37 0.77
Dec 31, 2006 0.31 0.74
Dec 31, 2005 0.29 0.70

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).